MicroRNA-34a is a tumor suppressor in choriocarcinoma via regulation of Delta-like1.

Abstract:

BACKGROUND:Choriocarcinoma is a gestational trophoblastic tumor which causes high mortality if left untreated. MicroRNAs (miRNAs) are small non protein-coding RNAs which inhibit target gene expression. The role of miRNAs in choriocarcinoma, however, is not well understood. In this study, we examined the effect of miR-34a in choriocarcinoma. METHODS:MiR-34a was either inhibited or ectopically expressed transiently in two choriocarcinoma cell lines (BeWo and JEG-3) respectively. Its actions on cell invasion, proliferation and colony formation at low cell density were examined. The miR-34a putative target Notch ligand Delta-like 1 (DLL1) was identified by adoption of different approaches including: in-silico analysis, functional luciferase assay and western blotting. Real-time quantitative polymerase chain reaction was used to quantify changes in the expression of matrix proteinase in the treated cells. To nullify the effect of miR-34a ectopic expression, we activated Notch signaling through force-expression of the Notch intracellular domain in the miR-34a force-expressed cells. In addition, we studied the importance of DLL1 in BeWo cell invasion through ligand stimulation and antibody inhibition. Furthermore, the induction in tumor formation of miR-34a-inhibited BeWo cells in SCID mice was investigated. RESULTS:Transient miR-34a force-expression significantly suppressed cell proliferation and invasion in BeWo and JEG-3 cells. In silicon miRNA target prediction, luciferase functional assays and Western blotting analysis demonstrated that miR-34a regulated DLL1 expression in both cell lines. Although force-expression of miR-34a suppressed the expression of DLL1 and NOTCH1, the extent of suppression was higher in DLL1 than NOTCH1 in both cell lines. MiR-34a-mediated DLL1 suppression led to reduced matrix metallopeptidase 9 and urokinase-type plasminogen activator expression. The effect of miR-34a on cell invasion was partially nullified by Notch signaling activation. DLL1 ligand stimulated while anti-DLL1 antibody treatment suppressed cell invasion. Mice inoculated with BeWo cells transfected with miR-34a inhibitor had significantly larger xenografts and stronger DLL1 expression than those with cells transfected with the control inhibitor. CONCLUSIONS:MiR-34a reduced cell proliferation and invasiveness, at least, partially through its inhibitory effect on DLL1.

journal_name

BMC Cancer

journal_title

BMC cancer

authors

Pang RT,Leung CO,Lee CL,Lam KK,Ye TM,Chiu PC,Yeung WS

doi

10.1186/1471-2407-13-25

subject

Has Abstract

pub_date

2013-01-18 00:00:00

pages

25

issn

1471-2407

pii

1471-2407-13-25

journal_volume

13

pub_type

杂志文章
  • A multicentre randomised controlled trial to evaluate the efficacy, morbidity and functional outcome of endoscopic transanal proctectomy versus laparoscopic proctectomy for low-lying rectal cancer (ETAP-GRECCAR 11 TRIAL): rationale and design.

    abstract:BACKGROUND:Total mesorectal excision is the standard surgical treatment for mid- and low-rectal cancer. Laparoscopy represents a clear leap forward in the management of rectal cancer patients, offering significant improvements in post-operative measures such as pain, first bowel movement, and hospital length of stay. H...

    journal_title:BMC cancer

    pub_type: 杂志文章,多中心研究,随机对照试验

    doi:10.1186/s12885-017-3200-1

    authors: Lelong B,de Chaisemartin C,Meillat H,Cournier S,Boher JM,Genre D,Karoui M,Tuech JJ,Delpero JR,French Research Group of Rectal Cancer Surgery (GRECCAR).

    更新日期:2017-04-11 00:00:00

  • BRAF mutant colorectal cancer: ErbB2 expression levels as predictive factor for the response to combined BRAF/ErbB inhibitors.

    abstract:BACKGROUND:Colorectal cancer (CRC) is a heterogeneous disease with a complex biology and a wide number of altered genes such as BRAF, KRAS and PIK3CA. Advances with new-targeted therapies have been achieved and available treating options have prolonged patient's survival. However, BRAF-mutated CRC patients remain unres...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-020-6586-0

    authors: Miele E,Abballe L,Spinelli GP,Besharat ZM,Catanzaro G,Chiacchiarini M,Vacca A,Po A,Capalbo C,Ferretti E

    更新日期:2020-02-17 00:00:00

  • Efficacy of bevacizumab combined with chemotherapy in the treatment of HER2-negative metastatic breast cancer: a network meta-analysis.

    abstract:BACKGROUND:It is not known what combination of bevacizumab and chemotherapy agents is the best therapeutic regimen. Comparative study results among the efficacies of bevacizumab plus chemotherapy remain controversial in patients with HER2-negative metastatic breast cancer. METHODS:We searched Pubmed, Embase, and Cochr...

    journal_title:BMC cancer

    pub_type: 杂志文章,meta分析

    doi:10.1186/s12885-020-6674-1

    authors: Sun Z,Lan X,Xu S,Li S,Xi Y

    更新日期:2020-03-04 00:00:00

  • Case report: PET/CT, a cautionary tale.

    abstract:BACKGROUND:The use of combined positron emission tomography/computerised tomography (PET/CT) scanners in oncology has been shown to improve the staging of tumours and the detection of relapses. However, mis-registration errors are increasingly recognised to be a common pitfall of PET/CT studies. CASE PRESENTATION:We r...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-7-147

    authors: Wang J,Cook G,Frank J,Dina R,Livni N,Lynn J,Fleming W,Seckl MJ

    更新日期:2007-08-03 00:00:00

  • Hormone signaling via androgen receptor affects breast cancer and prostate cancer in a male patient: A case report.

    abstract:BACKGROUND:Male breast cancer (MBC) is rare, accounting for only around 1% of all breast cancers. Most MBCs are hormone-driven. Not only the estrogen receptor (ER), but also other steroid hormone receptors, including the androgen receptor (AR) and progesterone receptor (PgR) are expressed in MBC. AR activation in breas...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-018-5216-6

    authors: Takuwa H,Tsuji W,Shintaku M,Yotsumoto F

    更新日期:2018-12-22 00:00:00

  • The role of major duct excision and microdochectomy in the detection of breast carcinoma.

    abstract:BACKGROUND:The association of nipple discharge with breast carcinoma has resulted in numerous women undergoing exploratory surgery to exclude malignancy. The aim of this study was to determine whether pre-operative factors can identify those patients that are most at risk of carcinoma. METHODS:All patients over a 14-y...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-6-164

    authors: Dillon MF,Mohd Nazri SR,Nasir S,McDermott EW,Evoy D,Crotty TB,O'Higgins N,Hill AD

    更新日期:2006-06-23 00:00:00

  • The maximum standardized uptake value of 18 F-FDG PET scan to determine prognosis of hormone-receptor positive metastatic breast cancer.

    abstract:BACKGROUND:Whether PET scan maximum standard uptake value (SUVmax) could differentiate luminal A from luminal B and help predict the survival of metastatic breast cancer (MBC) patients with luminal subtype is still unknown and need to be investigated. METHODS:305 MBC patients with luminal subtypes were screened with P...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-13-42

    authors: Zhang J,Jia Z,Ragaz J,Zhang YJ,Zhou M,Zhang YP,Li G,Wang BY,Wang ZH,Hu XC

    更新日期:2013-01-31 00:00:00

  • Targeting EGFR/HER2 pathways enhances the antiproliferative effect of gemcitabine in biliary tract and gallbladder carcinomas.

    abstract:BACKGROUND:Advanced biliary tract carcinomas (BTCs) have poor prognosis and limited therapeutic options. Therefore, it is crucial to combine standard therapies with molecular targeting. In this study EGFR, HER2, and their molecular transducers were analysed in terms of mutations, amplifications and over-expression in a...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-10-631

    authors: Pignochino Y,Sarotto I,Peraldo-Neia C,Penachioni JY,Cavalloni G,Migliardi G,Casorzo L,Chiorino G,Risio M,Bardelli A,Aglietta M,Leone F

    更新日期:2010-11-18 00:00:00

  • Tight correlation between expression of the Forkhead transcription factor FOXM1 and HER2 in human breast cancer.

    abstract:BACKGROUND:FOXM1 regulates expression of cell cycle related genes that are essential for progression into DNA replication and mitosis. Consistent with its role in proliferation, elevated expression of FOXM1 has been reported in a variety of human tumour entities. FOXM1 is a gene of interest because recently chemical in...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-8-42

    authors: Bektas N,Haaf At,Veeck J,Wild PJ,Lüscher-Firzlaff J,Hartmann A,Knüchel R,Dahl E

    更新日期:2008-02-06 00:00:00

  • Quality of life after cancer-How the extent of impairment is influenced by patient characteristics.

    abstract:BACKGROUND:Although this effect is well known, tailored treatment methods have not yet been broadly adopted. The aim of this study was to identify those patient characteristics that most influence the impairment of quality of life and thus to identify those patients who need and can benefit most from specific intervent...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-016-2822-z

    authors: Peters E,Mendoza Schulz L,Reuss-Borst M

    更新日期:2016-10-10 00:00:00

  • Malignant transformation of vaginal adenosis to clear cell carcinoma without prenatal diethylstilbestrol exposure: a case report and literature review.

    abstract:BACKGROUND:We report an extremely rare case of vaginal clear cell carcinoma, which originated from the malignant transformation of vaginal adenosis without prenatal diethylstilbestrol (DES) exposure. CASE PRESENTATION:In this case, the patient was a Chinese woman with a history of two decades of intermittent vaginal p...

    journal_title:BMC cancer

    pub_type: 杂志文章,评审

    doi:10.1186/s12885-019-6026-1

    authors: Pang L,Li L,Zhu L,Lang J,Bi Y

    更新日期:2019-08-13 00:00:00

  • Concurrent chemoradiotherapy with or without cetuximab for stage II to IVb nasopharyngeal carcinoma: a case-control study.

    abstract:BACKGROUND:This study aimed to evaluate the long-term outcome and toxicities in patients with locoregionally advanced nasopharyngeal carcinoma (NPC) treated by concurrent chemoradiotherapy (CCRT) with/without adding cetuximab. METHODS:A total of 62 patients treated with CCRT plus cetuximab were matched with 124 patien...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-017-3552-6

    authors: Li Y,Chen QY,Tang LQ,Liu LT,Guo SS,Guo L,Mo HY,Chen MY,Guo X,Cao KJ,Qian CN,Zeng MS,Bei JX,Shao JY,Sun Y,Tan J,Chen S,Ma J,Zhao C,Mai HQ

    更新日期:2017-08-24 00:00:00

  • Increasing of malignancy of breast cancer cells after cryopreservation: molecular detection and activation of angiogenesis after CAM-xenotransplantation.

    abstract:BACKGROUND:Ovarian tissue cryopreservation has a wide range of cancerous indications. Avoiding relapse becomes a specific concern that clinicians frequently encounter. The data about the comparative viability of cancer cells after cryopreservation are limited. This study aimed to evaluate the effect of cryopreservation...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-020-07227-z

    authors: Du X,Todorov P,Isachenko E,Rahimi G,Mallmann P,Meng Y,Isachenko V

    更新日期:2020-08-12 00:00:00

  • Risk factors associated with fatal pulmonary hemorrhage in locally advanced non-small cell lung cancer treated with chemoradiotherapy.

    abstract:BACKGROUND:The purpose of this study was to identify the risk factors associated with fatal pulmonary hemorrhage (PH) in patients with locally advanced non-small cell lung cancer (NSCLC), treated with chemoradiotherapy. METHODS:The medical records of 583 patients with locally advanced NSCLC, who were treated with chem...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-12-27

    authors: Ito M,Niho S,Nihei K,Yoh K,Ohmatsu H,Ohe Y

    更新日期:2012-01-20 00:00:00

  • Risk of second primary Cancer among bladder Cancer patients: a population-based cohort study in Korea.

    abstract:BACKGROUND:For the expanding population of bladder cancer survivors in Korea, the development of subsequent cancers is a significant concern. Here, we provide the second primary cancer incidence rates and types in Korean patients with bladder cancer. METHODS:Using population-based data from the Korea Central Cancer Re...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-018-4530-3

    authors: Kwon WA,Joung JY,Lim J,Oh CM,Jung KW,Kim SH,Seo HK,Park WS,Chung J,Lee KH,Won YJ

    更新日期:2018-05-31 00:00:00

  • Chemotherapy and radiation therapy elicits tumor specific T cell responses in a breast cancer patient.

    abstract:BACKGROUND:Experimental evidence and clinical studies in breast cancer suggest that some anti-tumor therapy regimens generate stimulation of the immune system that accounts for tumor clinical responses, however, demonstration of the immunostimulatory power of these therapies on cancer patients continues to be a formida...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-016-2625-2

    authors: Bernal-Estévez D,Sánchez R,Tejada RE,Parra-López C

    更新日期:2016-08-03 00:00:00

  • Trends in pancreatic adenocarcinoma incidence and mortality in the United States in the last four decades; a SEER-based study.

    abstract:BACKGROUND:Pancreatic cancer is the fourth-leading cause of cancer deaths in the United States. The silent nature of the disease and its poor prognosis, the need for further research, along with the need to assess the outcomes of current approaches necessitate an ongoing evaluation of the epidemiology and mortality-tre...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-018-4610-4

    authors: Saad AM,Turk T,Al-Husseini MJ,Abdel-Rahman O

    更新日期:2018-06-25 00:00:00

  • Microenvironment in neuroblastoma: isolation and characterization of tumor-derived mesenchymal stromal cells.

    abstract:BACKGROUND:It has been proposed that mesenchymal stromal cells (MSCs) promote tumor progression by interacting with tumor cells and other stroma cells in the complex network of the tumor microenvironment. We characterized MSCs isolated and expanded from tumor tissues of pediatric patients diagnosed with neuroblastomas ...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-018-5082-2

    authors: Pelizzo G,Veschi V,Mantelli M,Croce S,Di Benedetto V,D'Angelo P,Maltese A,Catenacci L,Apuzzo T,Scavo E,Moretta A,Todaro M,Stassi G,Avanzini MA,Calcaterra V

    更新日期:2018-11-27 00:00:00

  • Relevance of internal time and circadian robustness for cancer patients.

    abstract:BACKGROUND:Adequate circadian timing of cancer treatment schedules (chronotherapy) can enhance tolerance and efficacy several-fold in experimental and clinical situations. However, the optimal timing varies according to sex, genetic background and lifestyle. Here, we compute the individual phase of the Circadian Timing...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-016-2319-9

    authors: Ortiz-Tudela E,Innominato PF,Rol MA,Lévi F,Madrid JA

    更新日期:2016-04-21 00:00:00

  • Apoptosis-induced ectodomain shedding of hypoxia-regulated carbonic anhydrase IX from tumor cells: a double-edged response to chemotherapy.

    abstract:BACKGROUND:Carbonic anhydrase IX (CA IX) is a tumor-associated, highly active, transmembrane carbonic anhydrase isoform regulated by hypoxia and implicated in pH control and adhesion-migration-invasion. CA IX ectodomain (ECD) is shed from the tumor cell surface to serum/plasma of patients, where it can signify cancer p...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-016-2267-4

    authors: Vidlickova I,Dequiedt F,Jelenska L,Sedlakova O,Pastorek M,Stuchlik S,Pastorek J,Zatovicova M,Pastorekova S

    更新日期:2016-03-19 00:00:00

  • Circular RNA hsa_circ_0000282 contributes to osteosarcoma cell proliferation by regulating miR-192/XIAP axis.

    abstract:BACKGROUND:Circular RNAs (circRNAs) have emerged as a novel category of non-coding RNA, which exhibit a pivotal effect on regulating gene expression and biological functions, yet how circRNAs function in osteosarcoma (OSA) still demands further investigation. This study aimed at probing into the function of hsa_circ_00...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-020-07515-8

    authors: Li H,He L,Tuo Y,Huang Y,Qian B

    更新日期:2020-10-23 00:00:00

  • High BANCR expression is associated with worse prognosis in human malignant carcinomas: an updated systematic review and meta-analysis.

    abstract:BACKGROUND:BRAF-activated noncoding RNA (BANCR) is aberrantly expressed in various tumor tissues and has been confirmed to function as a tumor suppressor or oncogene in many types of cancers. Considering the conflicting results and insufficient sampling, a meta-analysis was performed to explore the prognostic value of ...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-020-07177-6

    authors: Fang S,Liu Z,Guo Q,Chen C,Ke X,Xu G

    更新日期:2020-09-09 00:00:00

  • Prevalence of hepatitis B and C and sensibility of a selective screening questionnaire in patients receiving chemotherapy for solid tumors.

    abstract:BACKGROUND:Reactivation of hepatitis B or C virus can occur in patients undergoing chemotherapy. Recommendations for selective or systematic hepatitis B virus testing prior chemotherapy for solid tumors differ. The primary aim was to determine the seroprevalence of hepatitis B or C in a low endemic country. The second ...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-015-2033-z

    authors: Brasseur M,Heurgué-Berlot A,Barbe C,Brami C,Rey JB,Vella-Boucaud J,Dabouz F,Deslée G,Grange F,Volet J,Bouché O

    更新日期:2015-12-23 00:00:00

  • MicroRNA response to hypoxic stress in soft tissue sarcoma cells: microRNA mediated regulation of HIF3α.

    abstract:BACKGROUND:Hypoxia is often encountered in solid tumors and known to contribute to aggressive tumor behavior, radiation- and chemotherapy resistance resulting in a poor prognosis for the cancer patient. MicroRNAs (miRNAs) play a role in the regulation of the tumor cell response to hypoxia, however, not much is known ab...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-14-429

    authors: Gits CM,van Kuijk PF,de Rijck JC,Muskens N,Jonkers MB,van IJcken WF,Mathijssen RH,Verweij J,Sleijfer S,Wiemer EA

    更新日期:2014-06-13 00:00:00

  • Detection of circulating tumor cells in blood of metastatic breast cancer patients using a combination of cytokeratin and EpCAM antibodies.

    abstract:BACKGROUND:Circulating tumor cells (CTCs) are detectable in peripheral blood of metastatic breast cancer patients (MBC). In this paper we evaluate a new CTC separation method based on a combination of anti-EpCAM- and anti-cytokeratin magnetic cell separation with the aim to improve CTC detection with low target antigen...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-12-206

    authors: Weissenstein U,Schumann A,Reif M,Link S,Toffol-Schmidt UD,Heusser P

    更新日期:2012-05-30 00:00:00

  • Patterns of follow up and survivorship care for people with colorectal cancer in new South Wales, Australia: a population-based survey.

    abstract:BACKGROUND:The incidence and survival rates for colorectal cancer in Australia are among the highest in the world. With population growth and ageing there are increasing numbers of colorectal cancer survivors in the community, yet little is known of their ongoing follow up and survivorship care experiences. This study ...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-018-4297-6

    authors: Young JM,Durcinoska I,DeLoyde K,Solomon MJ

    更新日期:2018-03-27 00:00:00

  • Altered glutamyl-aminopeptidase activity and expression in renal neoplasms.

    abstract:BACKGROUND:Advances in the knowledge of renal neoplasms have demonstrated the implication of several proteases in their genesis, growth and dissemination. Glutamyl-aminopeptidase (GAP) (EC. 3.4.11.7) is a zinc metallopeptidase with angiotensinase activity highly expressed in kidney tissues and its expression and activi...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-14-386

    authors: Blanco L,Sanz B,Perez I,Sánchez CE,Cándenas ML,Pinto FM,Gil J,Casis L,López JI,Larrinaga G

    更新日期:2014-05-30 00:00:00

  • CD73 promotes proliferation and migration of human cervical cancer cells independent of its enzyme activity.

    abstract:BACKGROUND:CD73 has both enzymatic and non-enzymatic functions in cells. As a nucleotidase, CD73 plays its enzymatic function by catalyzing the hydrolysis of AMP into adenosine and phosphate. In addition to this, accumulating data have shown that CD73 is a key regulatory molecule involved in cancer growth and metastasi...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-017-3128-5

    authors: Gao ZW,Wang HP,Lin F,Wang X,Long M,Zhang HZ,Dong K

    更新日期:2017-02-15 00:00:00

  • Colon cancer molecular subtypes identified by expression profiling and associated to stroma, mucinous type and different clinical behavior.

    abstract:BACKGROUND:Colon cancer patients with the same stage show diverse clinical behavior due to tumor heterogeneity. We aimed to discover distinct classes of tumors based on microarray expression patterns, to analyze whether the molecular classification correlated with the histopathological stages or other clinical paramete...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-12-260

    authors: Perez-Villamil B,Romera-Lopez A,Hernandez-Prieto S,Lopez-Campos G,Calles A,Lopez-Asenjo JA,Sanz-Ortega J,Fernandez-Perez C,Sastre J,Alfonso R,Caldes T,Martin-Sanchez F,Diaz-Rubio E

    更新日期:2012-06-19 00:00:00

  • Activation and function of receptor tyrosine kinases in human clear cell renal cell carcinomas.

    abstract:BACKGROUND:The receptor tyrosine kinases (RTKs) play critical roles in the development of cancers. Clear cell renal cell carcinoma (ccRCC) accounts for 75% of the RCC. The previous studies on the RTKs in ccRCCs mainly focused on their gene expressions. The activation and function of the RTKs in ccRCC have not been full...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-019-6159-2

    authors: Zhang Q,Liu JH,Liu JL,Qi CT,Yan L,Chen Y,Yu Q

    更新日期:2019-11-05 00:00:00